These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26458285)

  • 21. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
    Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
    Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
    Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
    Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone invasion-targeted chemotherapy with a novel anionic platinum complex (3Pt) for oral squamous cell carcinoma.
    Kasahara Y; Endo K; Ueno T; Ueno H; Moriyama-Kita M; Odani A; Yoshizaki T
    Cancer Sci; 2019 Oct; 110(10):3288-3295. PubMed ID: 31348586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
    Zhou X; Ren Y; Liu A; Han L; Zhang K; Li S; Li P; Li P; Kang C; Wang X; Zhang L
    Oncol Rep; 2014 May; 31(5):2173-80. PubMed ID: 24676554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy.
    Srivastava G; Matta A; Fu G; Somasundaram RT; Datti A; Walfish PG; Ralhan R
    Mol Oncol; 2015 Oct; 9(8):1720-35. PubMed ID: 26115765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma.
    Li Q; Liu X; Yan W; Chen Y
    Aging (Albany NY); 2020 Dec; 13(2):2593-2603. PubMed ID: 33323546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoid interferon-induced mortality19 (GRIM19) inhibits proliferation and invasion in rheumatoid arthritis fibroblast-like synoviocytes.
    Zhao D; Jiang Z; Wang Z; Gao J
    Biomed Pharmacother; 2018 Feb; 98():719-725. PubMed ID: 29306209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic and preventive effects of an epidermal growth factor receptor inhibitor on oral squamous cell carcinoma.
    Ge H; Liu H; Fu Z; Sun Z
    J Int Med Res; 2012; 40(2):455-66. PubMed ID: 22613406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study.
    Yoshimura H; Yoshida H; Matsuda S; Ryoke T; Ohta K; Ohmori M; Yamamoto S; Kiyoshima T; Kobayashi M; Sano K
    Mol Med Rep; 2019 Aug; 20(2):1139-1148. PubMed ID: 31173211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
    Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
    J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
    Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
    Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
    Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
    Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.
    Yang Q; Zhang S; Kang M; Dong R; Zhao J
    Oncol Rep; 2015 May; 33(5):2537-44. PubMed ID: 25738402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grim-19 expressed by recombinant adenovirus for esophageal neoplasm target therapy.
    Song J; Shi W; Wang W; Zhang Y; Zheng S
    Mol Med Rep; 2018 May; 17(5):6667-6674. PubMed ID: 29488605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.
    Hung CC; Chien CY; Chiang WF; Lin CS; Hour TC; Chen HR; Wang LF; Ko JY; Chang CH; Chen JY
    Oncotarget; 2015 Feb; 6(6):4110-25. PubMed ID: 25686830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.